STOCK TITAN

Enhabit - EHAB STOCK NEWS

Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.

Enhabit Inc (EHAB) provides essential home health and hospice care services across the United States, delivering Medicare-certified skilled nursing and compassionate end-of-life support directly to patients' homes. This news hub offers investors and industry professionals a centralized source for tracking the company's operational developments and market position.

Access timely updates on earnings reports, strategic partnerships, regulatory compliance milestones, and leadership announcements. Our curated collection includes press releases about service expansions, quality care initiatives, and technology integrations that maintain Enhabit's competitive edge in home-based healthcare.

Key updates cover both segments of Enhabit's operations: home health services focused on rehabilitation and chronic care management, plus hospice services emphasizing patient comfort and family support. Stay informed about operational metrics, industry recognition, and evolving care models without promotional bias.

Bookmark this page for streamlined access to verified information about Enhabit's clinical advancements and financial performance. Check back for objective reporting on how the company navigates healthcare regulations and meets growing demand for personalized home care solutions.

Rhea-AI Summary

Enhabit Inc (NYSE: EHAB) reported Q3 2024 financial results with net service revenue of $253.6 million, down 1.8% year-over-year. The company reported a net loss of $110.2 million and Adjusted EBITDA of $24.5 million, up 5.6%. Home health segment saw non-Medicare admissions increase 20.1%, while hospice segment revenue grew 11% with average daily census up 6.9%. Due to lower recertifications and hurricane impacts, Enhabit revised its full-year 2024 guidance, with net service revenue now expected between $1,031-$1,046 million and Adjusted EBITDA between $98-$102 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
-
Rhea-AI Summary

Enhabit Home Health & Hospice (NYSE: EHAB) has been recognized as an Age-Friendly Health Systems Participant by the Institute for Healthcare Improvement (IHI). This recognition acknowledges Enhabit's commitment to implementing the 4Ms of Age-Friendly Care: What Matters, Medication, Mentation, and Mobility.

Bud Langham, executive vice president of clinical excellence & strategy at Enhabit, emphasized the company's dedication to providing the best possible care for older adults. The Age-Friendly Health Systems initiative, supported by The John A. Hartford Foundation and other partners, aims to improve care for older adults across various healthcare settings, including home-based care.

By participating in this movement, Enhabit joins a select group of healthcare systems worldwide working to tailor care to patients' goals and preferences, aligning with their vision of excellence in elder care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
none
-
Rhea-AI Summary

Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, has announced its participation in two upcoming investor conferences. The company's President and CEO Barb Jacobsmeyer and CFO Crissy Carlisle will attend:

  • Jefferies Healthcare Services "Back to School" Summit and Bus Tour on Aug. 28 in Nashville, Tenn.
  • 2024 Wells Fargo Healthcare Conference on Sept. 5 in Boston, Mass., including investor meetings and a fireside chat.

The fireside chat will be webcast live at 11 a.m. EDT and available for replay on Enhabit's investor website. Enhabit operates 256 home health locations and 112 hospice locations across 34 states, focusing on expanding patient care possibilities in the home through advanced technology and compassionate teams.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
conferences
News
Rhea-AI Summary

Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, has announced that CFO Crissy Carlisle will step down from her role. The company has initiated a comprehensive search for her successor. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities.

CEO Barb Jacobsmeyer praised Carlisle's contributions since Enhabit became a public company two years ago, highlighting her role in achieving business stability and positioning the organization for growth. Carlisle expressed pride in her accomplishments, including establishing a finance organization and enhancing the control environment.

Enhabit operates 256 home health locations and 112 hospice locations across 34 states. The company will hold a conference call to discuss its second quarter 2024 financial results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.05%
Tags
none
-
Rhea-AI Summary

Enhabit, Inc. (NYSE: EHAB) reported its Q2 2024 financial results, showing mixed performance across its home health and hospice segments. Key highlights include:

- Net service revenue of $260.6 million, down 0.6% year-over-year
- Net loss of $0.2 million, improved from a $74.4 million loss in Q2 2023
- Adjusted EBITDA of $25.2 million, up 5.4% year-over-year
- Earnings per share of $0.00, adjusted EPS of $0.07

The home health segment saw a 6.4% increase in total admissions, driven by a 25.2% growth in non-Medicare admissions. Hospice segment revenue grew 3.9%, with average daily census increasing 2.7% year-over-year. The company updated its full-year 2024 guidance, slightly lowering revenue expectations but maintaining its adjusted EBITDA forecast.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.05%
Tags
-
Rhea-AI Summary

AREX Capital Management, LP, owning 4.9% of Enhabit, Inc. (NYSE: EHAB), announced the election of Mark W. Ohlendorf to Enhabit's board of directors at the 2024 Annual Meeting. AREX expressed satisfaction with this outcome, highlighting Ohlendorf's financial expertise as important for improving Enhabit's financial reporting and investor communications. The campaign emphasized Enhabit's poor performance in its first two years as a public company and proposed strategies for improvement. AREX stressed that this result should not be seen as approval of the status quo, noting significant stockholder support for change. Both leading proxy advisors recommended replacing three directors. AREX urged the board to focus on correcting Enhabit's undervaluation and improving stockholder outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
none
Rhea-AI Summary

Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, has announced preliminary results from its 2024 Annual Meeting of Stockholders. According to the initial vote count, eight of Enhabit's director nominees have been elected to the board, along with one nominee proposed by AREX Capital Management, LP. The elected directors will serve one-year terms expiring in 2025.

The preliminary results indicate that stockholders have chosen a mix of Enhabit's nominees and an external candidate, potentially bringing fresh perspectives to the company's leadership. Enhabit operates 256 home health locations and 112 hospice locations across 34 states, leveraging advanced technology to deliver patient care in home settings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.63%
Tags
none
-
Rhea-AI Summary

AREX Capital Management, LP, owning 4.9% of Enhabit, Inc. (NYSE: EHAB) shares, has issued an open letter urging fellow stockholders to support change at the upcoming Annual Meeting on July 25, 2024. AREX emphasizes that two leading proxy advisory firms have recommended stockholders support board changes. The investment firm criticizes Enhabit's historical excuses for poor performance and empty promises, highlighting the opportunity to add industry-specific expertise to the board.

AREX encourages stockholders to vote for all seven of its nominees on the WHITE Proxy Card, believing this will ensure Enhabit has a board with the right experience to oversee management and drive operational improvements. Stockholders can visit www.rehabEHAB.com for additional information and to download AREX's comprehensive turnaround plan presentation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
none
-
Rhea-AI Summary

Enhabit (NYSE: EHAB) urges stockholders to vote FOR its nine nominees at the July 25 Annual Meeting to protect their investment value. The company highlights three consecutive quarters of strong operational results, including an expected Adjusted EBITDA of $24.5-$25.0 million and a $15 million debt reduction. Enhabit's Board emphasizes its fit-for-purpose composition with expertise in payors, hospital networks, and labor management.

The company criticizes AREX's proposed slate of directors for lacking relevant experience and warns that AREX's vague 'Five-Point Plan' and 'Transformation Committee' could derail Enhabit's progress. Enhabit recommends stockholders use the YELLOW proxy card to vote for its nominees, stressing the importance of maintaining momentum in its path to profitable growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
none
Rhea-AI Summary

Enhabit (NYSE: EHAB), a leading home health and hospice provider, has released preliminary results for Q2 2024. Key highlights include:

  • Adjusted EBITDA between $24.5 million and $25.0 million
  • Bank debt reduced by $15 million, including a $10 million payment on the revolving credit facility
  • 43% of non-Medicare visits now under payor innovation contracts at improved rates, up from 38% in Q1 2024
  • Home health admissions increased 6.4% year-over-year, driven by non-Medicare admissions
  • Hospice segment achieved monthly sequential growth in average daily census for the fifth consecutive month

The company reports continued business stabilization and positioning for profitable growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.06%
Tags
Enhabit

NYSE:EHAB

EHAB Rankings

EHAB Stock Data

387.69M
48.77M
3.23%
102.53%
2.54%
Medical Care Facilities
Services-home Health Care Services
Link
United States
DALLAS